Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study -- Company expects to submit ...

Eton Pharmaceuticals (ETON) announced positive results from its bioequivalence study of ET-600, a proprietary, patented oral solution of ...

Q4 2024 Earnings Call Transcript March 13, 2025 Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is ...

The education system in Andhra Pradesh is being systematically weakened under the coalition government, with Education ...

WHILE some people are losing sleep over a glut in condominium units, the Philippine industrial sector, once considered a “sleeping giant,” is now on the cusp of a major awakening in 2025, signalling a ...